JHS Svendgaard Laboratories (NSE:JHS) Debt-to-EBITDA : -4.12 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:JHS JHS Svendgaard Laboratories Ltd NSE:JHS
50 GF Score
Price ₹8.41
GF Value ₹22.91
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is JHS Svendgaard Laboratories Debt-to-EBITDA?

JHS Svendgaard Laboratories NSE:JHS +0.12% 50 Debt-to-EBITDA is -4.12 as of Mar. 2026. GuruFocus rates NSE:JHS with a GF Score™ of 50/100 and a GF Value™ of ₹22.91 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,556 Consumer Packaged Goods companies, JHS Svendgaard Laboratories ranks worse than 55.08% on this metric.

Debt-to-EBITDA measures a company's ability to pay off its debt.

JHS Svendgaard Laboratories's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was ₹93 Mil. JHS Svendgaard Laboratories's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2026 was ₹55 Mil. JHS Svendgaard Laboratories's annualized EBITDA for the quarter that ended in Mar. 2026 was ₹-36 Mil. JHS Svendgaard Laboratories's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 was -4.12.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for JHS Svendgaard Laboratories's Debt-to-EBITDA or its related term are showing as below:

NSE:JHS' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.62   Med: 0.74   Max: 2.45
Current: 2.45

During the past 13 years, the highest Debt-to-EBITDA Ratio of JHS Svendgaard Laboratories was 2.45. The lowest was -1.62. And the median was 0.74.

NSE:JHS's Debt-to-EBITDA is ranked worse than
55.08% of 1556 companies
in the Consumer Packaged Goods industry
Industry Median: 2.125 vs NSE:JHS: 2.45

JHS Svendgaard Laboratories  (NSE:JHS) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


JHS Svendgaard Laboratories Debt-to-EBITDA Related Terms


JHS Svendgaard Laboratories Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for JHS Svendgaard Laboratories's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JHS Svendgaard Laboratories Debt-to-EBITDA Chart

JHS Svendgaard Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.73 -0.94 1.54 -1.62 2.45

JHS Svendgaard Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.24 0.00 1.29 0.00 -4.12

NSE:JHS vs PG, CL, KVUE: Debt-to-EBITDA Comparison

For the Household & Personal Products subindustry, JHS Svendgaard Laboratories's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JHS Svendgaard Laboratories Debt-to-EBITDA vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, JHS Svendgaard Laboratories's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where JHS Svendgaard Laboratories's Debt-to-EBITDA falls into.


NSE:JHS
50GF Score
JHS Svendgaard Laboratories Ltd NSE:JHS
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JHS Svendgaard Laboratories Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

JHS Svendgaard Laboratories's Debt-to-EBITDA for the fiscal year that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(93.335 + 55.178) / 60.641
=2.45

JHS Svendgaard Laboratories's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(93.335 + 55.178) / -36.064
=-4.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2026) EBITDA data.

Frequently Asked Questions Learn more about Debt-to-EBITDA →
What does a Debt-to-EBITDA of -4.12 mean?
JHS Svendgaard Laboratories (NSE:JHS) has a Debt-to-EBITDA of -4.12 as of Mar. 2026. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on JHS Svendgaard Laboratories. According to the industry distribution chart, JHS Svendgaard Laboratories ranks #857 out of 1556 companies in the Consumer Packaged Goods industry, placing it in the top 55.1%.
Is JHS Svendgaard Laboratories' Debt-to-EBITDA too high?
JHS Svendgaard Laboratories' current Debt-to-EBITDA is -4.12. Based on the distribution chart, JHS Svendgaard Laboratories ranks #857 out of 1556 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, JHS Svendgaard Laboratories has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does JHS Svendgaard Laboratories' Debt-to-EBITDA compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, JHS Svendgaard Laboratories ranks #857 out of 1556 companies for Debt-to-EBITDA. This places JHS Svendgaard Laboratories in the lower half of its industry. The industry median Debt-to-EBITDA is 2.13. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Consumer Packaged Goods company?
The median Debt-to-EBITDA among Consumer Packaged Goods companies is 2.13, based on 1,556 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on JHS Svendgaard Laboratories. For the Consumer Packaged Goods industry, the median Debt-to-EBITDA is 2.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JHS Svendgaard Laboratories's current Debt-to-EBITDA is -4.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JHS Svendgaard Laboratories stock overvalued right now?
Based on GuruFocus' analysis, JHS Svendgaard Laboratories (NSE:JHS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹22.91, compared to a current price of ₹8.41 — trading 63.3% below its estimated fair value. The current Debt-to-EBITDA is -4.12. JHS Svendgaard Laboratories' overall GF Score™ is 50/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For JHS Svendgaard Laboratories (NSE:JHS), the current Debt-to-EBITDA is -4.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is JHS Svendgaard Laboratories (NSE:JHS) Overvalued in 2026?

Based on GuruFocus' analysis, JHS Svendgaard Laboratories stock appears to be undervalued. The current stock price of ₹8.41 is trading 63.3% below its estimated GF Value™ of ₹22.91. GuruFocus considers JHS Svendgaard Laboratories to be Possible Value Trap.

Key valuation signals for NSE:JHS:

  • Debt-to-EBITDA: -4.12
  • GF Value™: ₹22.91 vs. price of ₹8.41 (63.3% below fair value)
  • GF Score™: 50/100 with 3 warning signs

No single metric tells the full story. See the NSE:JHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


JHS Svendgaard Laboratories Business Description

Other Exchanges 532771:India
Address Mathura Road, B-1/E-23, Mohan Co-operative Industrial Area, New Delhi, IND, 110044
JHS Svendgaard Laboratories Ltd is engaged in manufacturing a range of oral and dental products for elite national and international brands. The main portfolio of the Group is to carry out manufacturing and exporting of oral care and hygiene products, including toothbrushes, toothpastes, mouthwash, sanizers, and job work of detergent powder. The Company is into manufacturing toothpaste, toothbrushes, Talcum, and Others. The toothbrushes segment generates the key revenue.
50GF Score

Get the complete analysis for NSE:JHS

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹8.41
Price
₹22.91
GF Value